Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer.
Sang W, Zhou Y, Chen H, Yu C, Dai L, Liu Z, Chen L, Fang Y, Ma P, Wu X, Kong H, Liao W, Jiang H, Qian J, Wang D, Liu YH.
Sang W, et al.
Cancer Discov. 2024 Feb 8;14(2):326-347. doi: 10.1158/2159-8290.CD-23-0584.
Cancer Discov. 2024.
PMID: 37824278